{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T01:18:12Z","timestamp":1780103892292,"version":"3.54.0"},"reference-count":150,"publisher":"Informa UK Limited","issue":"5","funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81273354; 81102320; 30873133; 30772629; 30371686"],"award-info":[{"award-number":["81273354; 81102320; 30873133; 30772629; 30371686"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Future Med. Chem."],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.4155\/fmc.15.19","type":"journal-article","created":{"date-parts":[[2015,4,29]],"date-time":"2015-04-29T10:11:39Z","timestamp":1430302299000},"page":"587-607","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":23,"title":["Recent Advance of the Hepatitis B Virus Inhibitors: A Medicinal Chemistry Overview"],"prefix":"10.1080","volume":"7","author":[{"given":"Haiyong","family":"Jia","sequence":"first","affiliation":[{"name":"Department of Medicinal Chemistry, Key Laboratory of Chemical Biology (Ministry of Education), School of Pharmaceutical Sciences, Shandong University, 44 West Culture Road, 250012, Jinan, Shandong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diwakar","family":"Rai","sequence":"additional","affiliation":[{"name":"Department of Medicinal Chemistry, Key Laboratory of Chemical Biology (Ministry of Education), School of Pharmaceutical Sciences, Shandong University, 44 West Culture Road, 250012, Jinan, Shandong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Zhan","sequence":"additional","affiliation":[{"name":"Department of Medicinal Chemistry, Key Laboratory of Chemical Biology (Ministry of Education), School of Pharmaceutical Sciences, Shandong University, 44 West Culture Road, 250012, Jinan, Shandong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuwang","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Medicinal Chemistry, Key Laboratory of Chemical Biology (Ministry of Education), School of Pharmaceutical Sciences, Shandong University, 44 West Culture Road, 250012, Jinan, Shandong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuemei","family":"Jiang","sequence":"additional","affiliation":[{"name":"Department of Hepatic Diseases, Jinan Infectious Disease Hospital, Jingshi Road, 173, 250021, Jinan, Shandong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyong","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Medicinal Chemistry, Key Laboratory of Chemical Biology (Ministry of Education), School of Pharmaceutical Sciences, Shandong University, 44 West Culture Road, 250012, Jinan, Shandong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2015,4,29]]},"reference":[{"key":"e_1_3_2_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biocel.2012.04.006"},{"key":"e_1_3_2_4_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01766-12"},{"key":"e_1_3_2_5_1","doi-asserted-by":"publisher","DOI":"10.1002\/rmv.554"},{"key":"e_1_3_2_6_1","doi-asserted-by":"publisher","DOI":"10.1111\/jvh.12033"},{"key":"e_1_3_2_7_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm901237x"},{"key":"e_1_3_2_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2012.05.012"},{"key":"e_1_3_2_9_1","doi-asserted-by":"publisher","DOI":"10.2174\/1568005033481141"},{"key":"e_1_3_2_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2012.09.006"},{"key":"e_1_3_2_11_1","doi-asserted-by":"publisher","DOI":"10.2174\/187152607782110077"},{"key":"e_1_3_2_12_1","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.79.3.1613-1622.2005"},{"key":"e_1_3_2_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2012.12.008"},{"issue":"6","key":"e_1_3_2_14_1","first-page":"a1279","article-title":"A proof-of-concept Phase 2a clinical trial with HBV\/HDV entry inhibitor Myrcludex B","volume":"60","author":"Bogomolov P","year":"2014","unstructured":"Bogomolov P , VoronkovaN, AllweissLet al. A proof-of-concept Phase 2a clinical trial with HBV\/HDV entry inhibitor Myrcludex B. Hepatology60 (6), a1279\u2013a1280 (2014).","journal-title":"Hepatology"},{"key":"e_1_3_2_15_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.24758"},{"key":"e_1_3_2_16_1","doi-asserted-by":"publisher","DOI":"10.1038\/nbt1389"},{"issue":"5","key":"e_1_3_2_17_1","first-page":"1729","article-title":"Cyclosporin A and its analogs inhibit hepatitis B virus entry into cultured hepatocytes through targeting a membrane transporter NTCP","volume":"59","author":"Watashi K","year":"2013","unstructured":"Watashi K , SluderA, DaitoTet al. Cyclosporin A and its analogs inhibit hepatitis B virus entry into cultured hepatocytes through targeting a membrane transporter NTCP. Hepatology59 (5), 1729\u20131737 (2013).","journal-title":"Hepatology"},{"key":"e_1_3_2_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2013.11.022"},{"key":"e_1_3_2_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2013.12.052"},{"issue":"1","key":"e_1_3_2_20_1","first-page":"1004","article-title":"NTCP transporter as novel target for anti-hepatitis B virus agents","volume":"1","author":"Tsukuda S","year":"2014","unstructured":"Tsukuda S , WatashiK. NTCP transporter as novel target for anti-hepatitis B virus agents. Clin. Res. Infect. Dis.1 (1), 1004 (2014).","journal-title":"Clin. Res. Infect. Dis."},{"key":"e_1_3_2_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2012.12.008"},{"key":"e_1_3_2_22_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms15022892"},{"key":"e_1_3_2_23_1","doi-asserted-by":"publisher","DOI":"10.1021\/mp300453k"},{"key":"e_1_3_2_24_1","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.23549"},{"key":"e_1_3_2_25_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199312163292503"},{"key":"e_1_3_2_26_1","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v19.i48.9189"},{"key":"e_1_3_2_27_1","first-page":"S169","article-title":"Anti HBs antibody level in response to hepatitis B immunoglobulin (HBIG) prophylaxis in liver transplant recipients","volume":"19","author":"Varghese J","year":"2013","unstructured":"Varghese J , CherianTP, ReddySMet al. Anti HBs antibody level in response to hepatitis B immunoglobulin (HBIG) prophylaxis in liver transplant recipients. Liver Transpl.19, S169\u2013S169 (2013).","journal-title":"Liver Transpl."},{"key":"e_1_3_2_28_1","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-201407151-02513"},{"key":"e_1_3_2_29_1","doi-asserted-by":"publisher","DOI":"10.1159\/000360948"},{"key":"e_1_3_2_30_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00473-12"},{"key":"e_1_3_2_31_1","unstructured":"Cuconati A GuoH BlockTMet al. WO2013130703A2. (2013)."},{"key":"e_1_3_2_32_1","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v12.i19.3006"},{"key":"e_1_3_2_33_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.24441"},{"key":"e_1_3_2_34_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1003613"},{"key":"e_1_3_2_35_1","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2013.00202"},{"key":"e_1_3_2_36_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0014460"},{"key":"e_1_3_2_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2007.09.026"},{"key":"e_1_3_2_38_1","unstructured":"Guo JT ChangJ BlockTM KinneyWA AlmondHR. WO 2013181584A3 (2014)."},{"key":"e_1_3_2_39_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI58847"},{"key":"e_1_3_2_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2013.04.108"},{"key":"e_1_3_2_41_1","doi-asserted-by":"publisher","DOI":"10.1186\/1743-422X-10-270"},{"key":"e_1_3_2_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2007.01.163"},{"key":"e_1_3_2_43_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12013-014-9847-1"},{"issue":"2","key":"e_1_3_2_44_1","first-page":"160","article-title":"[zinc finger protein designed to hepatitis B virus core promoter inhibit the transcription of HBV in HepG2.2.15 cells]","volume":"28","author":"Chen C","year":"2012","unstructured":"Chen C , LiX, GuoN, ZhangH, WuZJ. [zinc finger protein designed to hepatitis B virus core promoter inhibit the transcription of HBV in HepG2.2.15 cells]. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi28 (2), 160\u2013162 (2012).","journal-title":"Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi"},{"key":"e_1_3_2_45_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.1243462"},{"key":"e_1_3_2_46_1","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.20790"},{"key":"e_1_3_2_47_1","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.02555-09"},{"key":"e_1_3_2_48_1","doi-asserted-by":"publisher","DOI":"10.1002\/bit.20640"},{"key":"e_1_3_2_49_1","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.79.21.13483-13496.2005"},{"key":"e_1_3_2_50_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-291X(03)00351-6"},{"issue":"6","key":"e_1_3_2_51_1","first-page":"685","article-title":"The properties of an HBV surface antigen protein carrying the binding site for the receptor of hepatocytes\u2014its formation of surface antigen particles and secretion from discrete cell lines","volume":"36","author":"Yu XM","year":"1993","unstructured":"Yu XM , LiZP. The properties of an HBV surface antigen protein carrying the binding site for the receptor of hepatocytes\u2014its formation of surface antigen particles and secretion from discrete cell lines. Sci. China B.36 (6), 685\u2013692 (1993).","journal-title":"Sci. China B."},{"key":"e_1_3_2_52_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1872-034X.2007.00315.x"},{"key":"e_1_3_2_53_1","first-page":"125398","article-title":"HD-03\/ES: a herbal medicine inhibits hepatitis B surface antigen secretion in transfected human hepatocarcinoma PLC\/PRF\/5 Cells","volume":"2013","author":"Varma SR","year":"2013","unstructured":"Varma SR , SundaramR, GopumadhavanS, VidyashankarS, PatkiPS. HD-03\/ES: a herbal medicine inhibits hepatitis B surface antigen secretion in transfected human hepatocarcinoma PLC\/PRF\/5 Cells. Hepat. Res. Treat.2013, 125398 (2013).","journal-title":"Hepat. Res. Treat."},{"key":"e_1_3_2_54_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2009.09.013"},{"key":"e_1_3_2_55_1","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v13.i30.4103"},{"key":"e_1_3_2_56_1","doi-asserted-by":"publisher","DOI":"10.1002\/ptr.864"},{"key":"e_1_3_2_57_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00541-07"},{"key":"e_1_3_2_58_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm200696v"},{"key":"e_1_3_2_59_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2007.08.027"},{"key":"e_1_3_2_60_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmc.2008.12.007"},{"key":"e_1_3_2_61_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2014.04.002"},{"key":"e_1_3_2_62_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2005.06.005"},{"key":"e_1_3_2_63_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2011.12.115"},{"key":"e_1_3_2_64_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2007.01.002"},{"key":"e_1_3_2_65_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2009.02.122"},{"key":"e_1_3_2_66_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2008.07.012"},{"key":"e_1_3_2_67_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2009.10.006"},{"key":"e_1_3_2_68_1","doi-asserted-by":"publisher","DOI":"10.1021\/np8007864"},{"key":"e_1_3_2_69_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-981549"},{"key":"e_1_3_2_70_1","doi-asserted-by":"publisher","DOI":"10.1002\/cbdv.200890074"},{"key":"e_1_3_2_71_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2008.05.065"},{"key":"e_1_3_2_72_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2006.02.007"},{"key":"e_1_3_2_73_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmc.2009.12.038"},{"key":"e_1_3_2_74_1","doi-asserted-by":"publisher","DOI":"10.1248\/bpb.32.132"},{"key":"e_1_3_2_75_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2008.01.005"},{"key":"e_1_3_2_76_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmc.2008.05.029"},{"key":"e_1_3_2_77_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2005.11.073"},{"key":"e_1_3_2_78_1","doi-asserted-by":"publisher","DOI":"10.1111\/fcp.12053"},{"key":"e_1_3_2_79_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2003.08.001"},{"key":"e_1_3_2_80_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.42.12.3179"},{"key":"e_1_3_2_81_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.str.2013.06.013"},{"key":"e_1_3_2_82_1","doi-asserted-by":"publisher","DOI":"10.1021\/cb100275b"},{"key":"e_1_3_2_83_1","doi-asserted-by":"publisher","DOI":"10.1021\/ci200227u"},{"key":"e_1_3_2_84_1","doi-asserted-by":"publisher","DOI":"10.1093\/protein\/8.2.127"},{"key":"e_1_3_2_85_1","unstructured":"PyMol\n          . www.pymol.org"},{"key":"e_1_3_2_86_1","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.76.10.4848-4854.2002"},{"key":"e_1_3_2_87_1","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01360-08"},{"key":"e_1_3_2_88_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12072-011-9261-3"},{"key":"e_1_3_2_89_1","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00933-06"},{"key":"e_1_3_2_90_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0025096"},{"key":"e_1_3_2_91_1","doi-asserted-by":"publisher","DOI":"10.1002\/jmr.801"},{"key":"e_1_3_2_92_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2011.08.012"},{"key":"e_1_3_2_93_1","doi-asserted-by":"publisher","DOI":"10.3851\/IMP2152"},{"key":"e_1_3_2_94_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01091-13"},{"key":"e_1_3_2_95_1","doi-asserted-by":"publisher","DOI":"10.1002\/rcm.6710"},{"key":"e_1_3_2_96_1","doi-asserted-by":"publisher","DOI":"10.1038\/aps.2013.76"},{"key":"e_1_3_2_97_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01091-13"},{"key":"e_1_3_2_98_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2009.10.119"},{"key":"e_1_3_2_99_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.93.3.1060"},{"key":"e_1_3_2_100_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.virol.2010.11.005"},{"key":"e_1_3_2_101_1","doi-asserted-by":"publisher","DOI":"10.1128\/MMBR.64.1.51-68.2000"},{"issue":"9","key":"e_1_3_2_102_1","first-page":"e56","article-title":"Hepatitis B virus reverse transcriptase: diverse functions as classical and emerging targets for antiviral intervention","volume":"2","author":"Scott AJ","year":"2013","unstructured":"Scott AJ , JianmingH. Hepatitis B virus reverse transcriptase: diverse functions as classical and emerging targets for antiviral intervention. Emerg. Microbes Infect.2 (9), e56 (2013).","journal-title":"Emerg. Microbes Infect."},{"key":"e_1_3_2_103_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0003-9861(02)00004-8"},{"key":"e_1_3_2_104_1","unstructured":"Li Z PengZ LiYet al. A1 US20100311694 (2008)."},{"key":"e_1_3_2_105_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2006.01.003"},{"key":"e_1_3_2_106_1","doi-asserted-by":"publisher","DOI":"10.3390\/molecules15095878"},{"key":"e_1_3_2_107_1","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.75.10.4771-4779.2001"},{"key":"e_1_3_2_108_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1746.2009.05952.x"},{"issue":"1","key":"e_1_3_2_109_1","first-page":"90","article-title":"Formal total synthesis of alpha-elvucitabine","volume":"53","author":"Yin L","year":"2014","unstructured":"Yin L , ZhangLY, ZhangHL, TangLD, ZhaoGL. Formal total synthesis of alpha-elvucitabine. Indian Journal of Chemistry Section B-Organic Including Medicinal53 (1), 90\u201394 (2014).","journal-title":"Indian Journal of Chemistry Section B-Organic Including Medicinal"},{"key":"e_1_3_2_110_1","doi-asserted-by":"publisher","DOI":"10.4103\/0253-7613.96296"},{"key":"e_1_3_2_111_1","doi-asserted-by":"publisher","DOI":"10.1517\/14656566.2010.509345"},{"issue":"4","key":"e_1_3_2_112_1","first-page":"A6","article-title":"Hexadecyloxypropyl tenofovir (CMX157) has enhanced potency in vitro against NRTI-resistant HIV relative to tenofovir and a favourable preclinical profile","volume":"13","author":"Lanier ER","year":"2008","unstructured":"Lanier ER , LampertB, TrostL, PainterG, AlmondM. Hexadecyloxypropyl tenofovir (CMX157) has enhanced potency in vitro against NRTI-resistant HIV relative to tenofovir and a favourable preclinical profile. Antivir. Ther.13 (4), A6\u2013A6 (2008).","journal-title":"Antivir. Ther."},{"key":"e_1_3_2_113_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00460-07"},{"key":"e_1_3_2_114_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2006.09.036"},{"key":"e_1_3_2_115_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(05)81446-1"},{"key":"e_1_3_2_116_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-2005-915648"},{"key":"e_1_3_2_117_1","doi-asserted-by":"publisher","DOI":"10.1517\/13543784.12.8.1281"},{"key":"e_1_3_2_118_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI11100"},{"key":"e_1_3_2_119_1","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v20.i24.7707"},{"key":"e_1_3_2_120_1","doi-asserted-by":"publisher","DOI":"10.1021\/op200153s"},{"key":"e_1_3_2_121_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00263-09"},{"key":"e_1_3_2_122_1","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1M590"},{"key":"e_1_3_2_123_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm7012216"},{"key":"e_1_3_2_124_1","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2013-305138"},{"key":"e_1_3_2_125_1","first-page":"a693","article-title":"Week 96 analysis of a phase IIb study of the efficacy and safety of besifovir (LB80380) vs. entecavir in treatment-naive patients with chronic hepatitis B","volume":"58","author":"Yuen MF","year":"2013","unstructured":"Yuen MF , AhnSH, LeeKSet al. Week 96 analysis of a phase IIb study of the efficacy and safety of besifovir (LB80380) vs. entecavir in treatment-naive patients with chronic hepatitis B. Hepatology58, a693\u2013a694 (2013).","journal-title":"Hepatology"},{"key":"e_1_3_2_126_1","doi-asserted-by":"publisher","DOI":"10.5414\/CP201716"},{"key":"e_1_3_2_127_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(11)61355-X"},{"key":"e_1_3_2_128_1","doi-asserted-by":"publisher","DOI":"10.1517\/13543784.17.10.1581"},{"key":"e_1_3_2_129_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(06)80007-3"},{"key":"e_1_3_2_130_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkt532"},{"key":"e_1_3_2_131_1","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0b013e3182965d45"},{"key":"e_1_3_2_132_1","first-page":"A31","article-title":"Antiviral activity of tenofovir alafenamide (TAF) against major NRTI-resistant viruses: improvement over TDF\/TFV is driven by higher TFV-DP loading in target cells","volume":"18","author":"Margot N","year":"2013","unstructured":"Margot N , LiuY, BabusisD, MillerMD, CallebautC. Antiviral activity of tenofovir alafenamide (TAF) against major NRTI-resistant viruses: improvement over TDF\/TFV is driven by higher TFV-DP loading in target cells. Antivir. Ther.18, A31\u2013A31 (2013).","journal-title":"Antivir. Ther."},{"key":"e_1_3_2_133_1","first-page":"a675","article-title":"Twenty eight day safety and efficacy of tenofovir alafenamide (TAF) fumarate in chronic hepatitis B (CHB) patients","volume":"58","author":"Agarwal K","year":"2013","unstructured":"Agarwal K , FungSK, NguyenTTet al. Twenty eight day safety and efficacy of tenofovir alafenamide (TAF) fumarate in chronic hepatitis B (CHB) patients. Hepatology58, a675\u2013a675 (2013).","journal-title":"Hepatology"},{"key":"e_1_3_2_134_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0960-894X(02)00531-0"},{"key":"e_1_3_2_135_1","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01916-13"},{"key":"e_1_3_2_136_1","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.03000-13"},{"key":"e_1_3_2_137_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2013.06.007"},{"key":"e_1_3_2_138_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1003125"},{"key":"e_1_3_2_139_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2014.05.007"},{"key":"e_1_3_2_140_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01764-09"},{"key":"e_1_3_2_141_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm101325h"},{"key":"e_1_3_2_142_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2011.06.071"},{"key":"e_1_3_2_143_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2014.03.060"},{"key":"e_1_3_2_144_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmc.2005.08.041"},{"key":"e_1_3_2_145_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmc.2005.11.033"},{"key":"e_1_3_2_146_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00894-010-0873-7"},{"key":"e_1_3_2_147_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm060330f"},{"key":"e_1_3_2_148_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12250-008-2945-8"},{"key":"e_1_3_2_149_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmc.2010.05.076"},{"key":"e_1_3_2_150_1","doi-asserted-by":"publisher","DOI":"10.1002\/ardp.201000167"},{"key":"e_1_3_2_151_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2007.03.005"},{"key":"e_1_3_2_152_1","doi-asserted-by":"publisher","DOI":"10.1111\/cpr.12117"}],"container-title":["Future Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.4155\/fmc.15.19","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,23]],"date-time":"2024-05-23T19:53:28Z","timestamp":1716494008000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.4155\/fmc.15.19"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4]]},"references-count":150,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,4]]}},"alternative-id":["10.4155\/fmc.15.19"],"URL":"https:\/\/doi.org\/10.4155\/fmc.15.19","relation":{},"ISSN":["1756-8919","1756-8927"],"issn-type":[{"value":"1756-8919","type":"print"},{"value":"1756-8927","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,4]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ifmc20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ifmc20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2015-04-29","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}